Marle completes the acquisition of SMB Medical
Marle, the leading European orthopaedic manufacturer backed by IK VII Fund since 2016, is accelerating its development through the acquisition of SMB Medical. Marle acquired 100 percent of the shares of SMB Holding AG, the parent company of SMB Medical SA, from Swiss Patrimonium Private Equity and various minority shareholders. The transaction was closed on 27 July 2016.
Based in Sant’Antonino, Switzerland, and with 85 employees, SMB Medical is a well-established contract manufacturer, producing tailor-made forged orthopaedic implants in all available medical alloys.
Unifying the complementary companies SMB Medical and Marle secures long-term prospects of both brands. Customers will benefit from an extended product range and broader geographic presence. The enlarged group consolidates its rank amongst the top three contract manufacturers for orthopaedic implants worldwide and as the European leader offering one-stop-shop solutions for their customers across the globe.
Heimo Wabusseg, CEO of SMB Medical, is enthusiastic about the acquisition: “By integrating with Marle, SMB Medical will further grow its position in the market by expanding its customer portfolio and investing in new technologies.”
“With SMB Medical, we gain access to attractive new customer segments. SMB Medical offers high quality standards and will enrich the group with a complementary and adjacent product range,” added Antonio Gil, CEO of Marle.
“The acquisition of SMB Medical is a key milestone in the development of Marle, adding additional manufacturing capabilities and a deep understanding of the market,” said Rémi Buttiaux, Partner at IK Investment Partners.
The financial terms of the transaction are not disclosed.
For any questions, please contact:
IK Investment Partners
Director Communications & ESG
Phone: +44 77 87 573 566